imperial chemical industries expected benefit results cancer study published today details revealed yesterday the study carried imperial cancer research fund concludes women early breast cancer better chance survival take hormonal therapy one main forms hormonal therapy oestrogen blocking drug called tamoxifen sold ici brand name nolvadex nolvadex launched 1973 largest selling cancer drug world turnover pounds 200m pounds 250m ici prepared comment studys potential impact profits the research involved 750000 women throughout world lasted five years most uk analysts believed study would positive ici dr jonathan gelles us securities house wertheim schroder said it clearly support growth product i would thought able increase unit use 20 25 per cent